Want to see HK:0439 full AI Analyst Report?
KuangChi Science Limited (0439) AI Stock Analysis
Top Page
KuangChi Science Limited
(HKEX:0439)
The score is held back primarily by weak financial performance (revenue contraction, persistent losses, and negative operating/free cash flow). Technical indicators add further pressure with a clear downtrend (price below key moving averages and negative MACD). The low-leverage balance sheet provides some stability, but the negative P/E and lack of dividend data offer limited valuation support.
KuangChi Science Limited (0439) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 329.40M
- Dividend Yield
- ―
- Average Volume (3M)
- 123.09K
- Price to Earnings (P/E)
- -2.2
- Beta (1Y)
- 0.41
- Revenue Growth
- -37.47%
- EPS Growth
- -278.35%
- Country
- Hong Kong
- Employees
- 125
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Aerospace & Defense
KuangChi Science Limited Business Overview & Revenue Model
Company Description
Genesis Scale Holdings Ltd. functions primarily as an investment holding entity. The company is actively involved in the development, manufacturing, and supply of innovative products designed for future technology sectors, in addition to offering a v...
KuangChi Science Limited Financial Statement Overview
Summary
Overall fundamentals are weak despite a strong balance sheet. Income statement performance is pressured by contracting revenue (~18% decline in 2025), persistent operating losses, and a sharply wider net loss in 2025. Cash flow is also poor with meaningfully negative operating and free cash flow in 2024–2025 (cash burn), though the balance sheet is a relative strength with low leverage and sizeable equity.
Income Statement
18Very NegativeBalance Sheet
74PositiveCash Flow
22Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.24M | 62.99M | 75.51M | 83.14M | 52.52M | 113.97M |
| Gross Profit | 14.84M | 16.39M | 20.74M | 14.68M | 10.83M | 41.73M |
| EBITDA | -31.39M | -23.84M | -77.39M | 173.00K | -56.85M | -24.80M |
| Net Income | -152.82M | -141.22M | -47.43M | -7.29M | -67.91M | -40.61M |
Balance Sheet | ||||||
| Total Assets | 2.41B | 3.24B | 3.20B | 1.83B | 1.98B | 2.77B |
| Cash, Cash Equivalents and Short-Term Investments | 227.28M | 210.97M | 152.56M | 263.55M | 164.96M | 318.68M |
| Total Debt | 0 | 65.53M | 90.49M | 115.50M | 141.74M | 178.95M |
| Total Liabilities | 263.94M | 475.27M | 474.25M | 334.40M | 362.69M | 545.67M |
| Stockholders Equity | 2.15B | 2.76B | 2.73B | 1.49B | 1.62B | 2.22B |
Cash Flow | ||||||
| Free Cash Flow | -61.68M | -110.30M | -94.51M | -52.68M | -92.82M | 82.82M |
| Operating Cash Flow | -54.69M | -107.84M | -80.87M | -43.59M | -77.91M | 105.22M |
| Investing Cash Flow | 252.92M | 138.41M | 162.66M | 43.10M | -104.25M | 369.21M |
| Financing Cash Flow | -110.90M | -29.59M | -21.65M | -22.38M | -23.79M | -325.97M |
KuangChi Science Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0439, the sentiment is Negative. The current price of 0.54 is above the 20-day moving average (MA) of 0.52, below the 50-day MA of 0.56, and below the 200-day MA of 0.74, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 51.51 is Neutral, neither overbought nor oversold. The STOCH value of 84.44 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0439.
KuangChi Science Limited Peers Comparison
Overall Rating
HK:250779Outperform
HK:217666Neutral
HK:235758Neutral- HK:043945Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2507 | 79Outperform | HKD 13.49B | 10.68 | 17.86% | 2.54% | 14.04% | 8.27% |
| HK:2176 | 66Neutral | HKD 322.00M | 7.77 | 35.60% | 22.39% | -21.68% | -55.57% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| HK:2357 | 58Neutral | HKD 23.16B | 12.18 | 4.44% | 2.29% | 1.92% | -17.88% |
| HK:0439 | 45Neutral | HKD 329.40M | -2.17 | -6.22% | ― | -37.47% | -278.35% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0439 | KuangChi Science Limited | 0.54 | -0.76 | -58.53% | |
| HK:2357 | AviChina Industry & Technology Co Class H | 2.90 | -0.96 | -24.88% | |
| HK:2176 | CCID Consulting Co. Ltd. Class H | 0.46 | -1.04 | -69.25% | |
| HK:2482 | Logory Logistics Technology Co. Ltd. Class H | 0.27 | -0.48 | -64.00% | |
| HK:2507 | Cirrus Aircraft Limited | 36.86 | -14.76 | -28.59% |
KuangChi Science Limited Corporate Events
Genesis Scale Posts Interim Loss as Revenue Declines and Costs Rise
Genesis Scale Holdings Limited, incorporated in Bermuda and listed on the Stock Exchange of Hong Kong, reported revenue of HK$18.9 million for the six months ended 30 June 2026, down from HK$33.7 million a year earlier. The Group’s business mix...
Genesis Scale Sets Board Meeting to Approve Interim Results and Consider Dividend
Genesis Scale Holdings Limited has scheduled a board meeting for 31 August 2026 to approve the announcement of its interim results for the six months ended 30 June 2026. The board will also consider the payment of an interim dividend, which could sig...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 26, 2026